LÖSLICHKEITSOPTIMIERUNG VON IMMUNBINDERN

European patent · EP2307455 · Deleted

Register entry

Publication number
EP2307455
Application number
EP09768694
Kind
European patent with effect for Switzerland and Liechtenstein
Status
Deleted
Specification
Granted
Filed
Jun 25, 2009
Published
Apr 13, 2011
Granted
Mar 22, 2017
Deleted
Feb 1, 2023
Reason
Revoked in opposition
IPC classes
C07K 16/22 (2006.01)
C07K 16/24 (2006.01)
Priority
US 75692 P 25.06.2008
PCT application
PCT/CH2009/000221 25.06.2009
PCT publication
WO2009/155725 30.12.2009
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Feb 1, 2023

    Change

    Published in Swissreg on 01.02.2023

  2. Jul 1, 2022

    Change

    Published in Swissreg on 01.07.2022

  3. Mar 22, 2017

    Granted

    Published in Swissreg on 22.03.2017

  4. Mar 22, 2017

    Corrected

    Published in Swissreg on 22.03.2017

Parties

Holder

ESBATech, an Alcon Biomedical Research Unit LLC

Wagistrasse 21, 8952 Schlieren

Inventor

BORRAS, Leonardo

CH-8952 Schlieren

URECH, David

8634 Hombrechtikon

Licensee

Cell Medica Switzerland AG in Liquidation

Delenex Therapeutics AG

Wagistrasse 27, 8952 Schlieren

Struck from the register

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.